Company intelligence / Profile preview

Drik

Oklahoma City, Oklahoma, United Statesdrikpanchang.com ↗

Ownership: Private
Development stage: Other

Overview

Drik specializes in preclinical toxicology and safety evaluation with expertise in advanced techniques such as 3D organotypic slice cultures to provide reliable de-risking strategies for clients' drug candidates. They offer integrated in vitro and in vivo testing to support regulatory compliance and decision-making during early drug development phases.

Modalities: Small molecule testing supportIn vitro assays including cell-based assays and organotypic slice culturesIn vivo toxicology studies using animal models
Industry: Contract Research Organization

Beyond the preview

Go deeper on Drik.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Drik.

Explore the full profile